Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

The efficacy and safety of immunosuppression for idiopathic membranous nephropathy (IMN) with nephrotic syndrome are still controversial. A systematic review and meta-analysis of randomized controlled trials (RCTs) was performed.